LAMEA Clot Management Devices Market
Asia-Pacific with increasing per capita income and high economic potentials would emerge as a prominent market during the forecast period. Based on the product type, the Clot Management Devices market is segmented into Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) devices, Neurovascular Embolectomy Devices and Inferior vena cava filters.
LAMEA AmericaClot Management Devices Market Overview
Blood Clotting also known as coagulation is the body’s response to an injury to prevent bleeding. However, a clot can be harmful when it forms abnormal flows through the vessels. The excessive formation of clots in the blood leads to different diseases such as brain stroke, heart attack and severe leg pain. Rising incidences of Heart failure, Brain disorder and other clot related problems have initiated the organizations to take measures against the problem. Clot management devices are one of the major treatments available in the market. Governments and healthcare organization have increased their investments for developing and enhancing the healthcare infrastructure. Such as The Healthcare Information Technology for Economic and Clinical Health Act is investing $20 billion in health information technology infrastructure. That is helping patients to avail the advanced medical facilities; hence it would affect the growth of the market.
LAMEA America Clot Management Devices Market Segmentation
Asia-Pacific with increasing per capita income and high economic potentials would emerge as a prominent market during the forecast period. Based on the product type, the Clot Management Devices market is segmented into Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) devices, Neurovascular Embolectomy Devices and Inferior vena cava filters. Based on End user Type, the market is segmented into Hospitals and Diagnostic Centres.
Based on Country, LAMEA Clot Management Devices market is segmented into Brazil, ARGENTINA, UAE, Saudi Arabia, South Africa, Nigeria and Rest of LAMEA. Brazil remained the dominant Country in the LAMEA Clot Management Devices market in 2015. UAE and Saudi Arabia would witness promising CAGR during the forecast period (2016-2022).
LAMEA AmericaClot Management Devices Market Key Companies
The report covers the analysis of key stake holders of the Clot Management Devices market. Key companies profiled in the report include Teleflex Inc.,Edwards Lifesciences Corporation,Medtronic Plc,Boston Scientific Corporation,Lemaitre Vascular, Inc.,Straub Medical AG,Cook Medical Inc. and Johnson & Johnson.
LAMEA AmericaClot Management Devices Market Segmentation
Scope of the Study
By Product Type
- Percutaneous Thrombectomy Devices
- Embolectomy Balloon Catheters
- Catheter-Directed Thrombolysis (CDT) devices
- Neurovascular Embolectomy Devices
- Inferior vena cava filters Professional
By End User
- Hospitals
- Diagnostic Centers
By Country
- Brazil
- ARGENTINA
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Company Profiled
- Teleflex Inc.
- Edwards Lifesciences Corporation
- Medtronic Plc
- Boston Scientific Corporation
- Lemaitre Vascular, Inc.
- Straub Medical AG
- Cook Medical Inc.
- Johnson & Johnson
Unique Offerings from KBV Research
- Exhaustive coverage of Clot Management Devices Market
- Highest number of market tables
- Unique “Market Research & Analytics Tool” to provide instant comparative analysis within the report
- Subscription based model available
- Free of cost quarterly updates
- Free of cost automatic pdf report generation
- Guaranteed best price
- Assured post sales research support with 10% customization free
Chapter 1-Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Clot Management Devices Market, by Product Type
1.4.2 LAMEA Clot Management Devices Market, by End User
1.4.3 LAMEA Clot Management Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Executive Summary
Chapter 3. Market Overview
3.1 Introduction
3.2 Drivers, Restraints and Opportunities
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. LAMEA Clot Management Market by Product
4.1 LAMEA Clot Management Market by Product
4.1.1 LAMEA Clot Management for Percutaneous Thrombectomy Devices Market by Country
4.1.2 LAMEA Clot Management for Embolectomy Balloon Catheters Market by Country
4.1.3 LAMEA Clot Management for Catheter-Directed Thrombolysis (CDT) devices Market by Country
4.1.4 LAMEA Clot Management for Neurovascular Embolectomy Devices Market by Country
4.1.5 LAMEA Clot Management for Other Product Market by Country
Chapter 5. LAMEA Clot Management Market by End User
5.1 Introduction
5.1.1 LAMEA Hospitals Clot Management Market by Country
5.1.2 LAMEA Diagnostic Centers Clot Management Market by Country
Chapter 6. LAMEA Clot Management Market by Country
6.1 Introduction
6.2 Brazil Clot Management Market
6.2.1 Brazil Clot Management Market by Product
6.2.2 Brazil Clot Management Market by End User
6.3 Argentina Clot Management Market
6.3.1 Argentina Clot Management Market by Product
6.3.2 Argentina Clot Management Market by End User
6.4 UAE Clot Management Market
6.4.1 UAE Clot Management Market by Product
6.4.2 UAE Clot Management Market by End User
6.5 Saudi Arabia Clot Management Market
6.5.1 Saudi Arabia Clot Management Market by Product
6.5.2 Saudi Arabia Clot Management Market by End User
6.6 South Africa Clot Management Market
6.6.1 South Africa Clot Management Market by Product
6.6.2 South Africa Clot Management Market by End User
6.7 Nigeria Clot Management Market
6.7.1 Nigeria Clot Management Market by Product
6.7.2 Nigeria Clot Management Market by End User
6.8 Rest of LAMEA Clot Management Market
6.8.1 Rest of LAMEA Clot Management Market by Product
6.8.2 Rest of LAMEA Clot Management Market by End User
Chapter 7. Company Profiles
7.1 Teleflex Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Edwards Lifesciences Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Medtronic Plc
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Boston Scientific Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Lemaitre Vascular, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expense
7.6 Straub Medical AG
7.6.1 Company Overview
7.7 Cook Medical Inc.
7.7.1 Company Overview
7.8 Johnson & Johnson
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Research & Development Expense
7.8.4 Segmental and Regional Analysis
List of Tables
TABLE 1 LAMEA CLOT MANAGEMENT MARKET, 2012 – 2015, USD MILLION
TABLE 2 LAMEA CLOT MANAGEMENT MARKET, 2016 – 2022, USD MILLION
TABLE 3 LAMEA CLOT MANAGEMENT MARKET BY PRODUCT, 2012 – 2015, USD MILLION
TABLE 4 LAMEA CLOT MANAGEMENT MARKET BY PRODUCT, 2016 – 2022, USD MILLION
TABLE 5 LAMEA CLOT MANAGEMENT FOR PERCUTANEOUS THROMBECTOMY DEVICES MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 6 LAMEA CLOT MANAGEMENT FOR PERCUTANEOUS THROMBECTOMY DEVICES MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 7 LAMEA CLOT MANAGEMENT FOR EMBOLECTOMY BALLOON CATHETERS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 8 LAMEA CLOT MANAGEMENT FOR EMBOLECTOMY BALLOON CATHETERS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 9 LAMEA CLOT MANAGEMENT FOR CATHETER-DIRECTED THROMBOLYSIS (CDT) DEVICES MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 10 LAMEA CLOT MANAGEMENT FOR CATHETER-DIRECTED THROMBOLYSIS (CDT) DEVICES MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 11 LAMEA CLOT MANAGEMENT FOR NEUROVASCULAR EMBOLECTOMY DEVICES MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 12 LAMEA CLOT MANAGEMENT FOR NEUROVASCULAR EMBOLECTOMY DEVICES MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 13 LAMEA CLOT MANAGEMENT FOR OTHER PRODUCT MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 14 LAMEA CLOT MANAGEMENT FOR OTHER PRODUCT MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 15 LAMEA CLOT MANAGEMENT MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 16 LAMEA CLOT MANAGEMENT MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 17 LAMEA HOSPITALS CLOT MANAGEMENT MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 18 LAMEA HOSPITALS CLOT MANAGEMENT MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 19 LAMEA DIAGNOSTIC CENTERS CLOT MANAGEMENT MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 20 LAMEA DIAGNOSTIC CENTERS CLOT MANAGEMENT MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 21 LAMEA CLOT MANAGEMENT MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 22 LAMEA CLOT MANAGEMENT MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 23 BRAZIL CLOT MANAGEMENT MARKET, 2012 – 2015, USD MILLION
TABLE 24 BRAZIL CLOT MANAGEMENT MARKET, 2016 – 2022, USD MILLION
TABLE 25 BRAZIL CLOT MANAGEMENT MARKET BY PRODUCT, 2012 – 2015, USD MILLION
TABLE 26 BRAZIL CLOT MANAGEMENT MARKET BY PRODUCT, 2016 – 2022, USD MILLION
TABLE 27 BRAZIL CLOT MANAGEMENT MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 28 BRAZIL CLOT MANAGEMENT MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 29 ARGENTINA CLOT MANAGEMENT MARKET, 2012 – 2015, USD MILLION
TABLE 30 ARGENTINA CLOT MANAGEMENT MARKET, 2016 – 2022, USD MILLION
TABLE 31 ARGENTINA CLOT MANAGEMENT MARKET BY PRODUCT, 2012 – 2015, USD MILLION
TABLE 32 ARGENTINA CLOT MANAGEMENT MARKET BY PRODUCT, 2016 – 2022, USD MILLION
TABLE 33 ARGENTINA CLOT MANAGEMENT MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 34 ARGENTINA CLOT MANAGEMENT MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 35 UAE CLOT MANAGEMENT MARKET, 2012 – 2015, USD MILLION
TABLE 36 UAE CLOT MANAGEMENT MARKET, 2016 – 2022, USD MILLION
TABLE 37 UAE CLOT MANAGEMENT MARKET BY PRODUCT, 2012 – 2015, USD MILLION
TABLE 38 UAE CLOT MANAGEMENT MARKET BY PRODUCT, 2016 – 2022, USD MILLION
TABLE 39 UAE CLOT MANAGEMENT MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 40 UAE CLOT MANAGEMENT MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 41 SAUDI ARABIA CLOT MANAGEMENT MARKET, 2012 – 2015, USD MILLION
TABLE 42 SAUDI ARABIA CLOT MANAGEMENT MARKET, 2016 – 2022, USD MILLION
TABLE 43 SAUDI ARABIA CLOT MANAGEMENT MARKET BY PRODUCT, 2012 – 2015, USD MILLION
TABLE 44 SAUDI ARABIA CLOT MANAGEMENT MARKET BY PRODUCT, 2016 – 2022, USD MILLION
TABLE 45 SAUDI ARABIA CLOT MANAGEMENT MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 46 SAUDI ARABIA CLOT MANAGEMENT MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 47 SOUTH AFRICA CLOT MANAGEMENT MARKET, 2012 – 2015, USD MILLION
TABLE 48 SOUTH AFRICA CLOT MANAGEMENT MARKET, 2016 – 2022, USD MILLION
TABLE 49 SOUTH AFRICA CLOT MANAGEMENT MARKET BY PRODUCT, 2012 – 2015, USD MILLION
TABLE 50 SOUTH AFRICA CLOT MANAGEMENT MARKET BY PRODUCT, 2016 – 2022, USD MILLION
TABLE 51 SOUTH AFRICA CLOT MANAGEMENT MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 52 SOUTH AFRICA CLOT MANAGEMENT MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 53 NIGERIA CLOT MANAGEMENT MARKET, 2012 – 2015, USD MILLION
TABLE 54 NIGERIA CLOT MANAGEMENT MARKET, 2016 – 2022, USD MILLION
TABLE 55 NIGERIA CLOT MANAGEMENT MARKET BY PRODUCT, 2012 – 2015, USD MILLION
TABLE 56 NIGERIA CLOT MANAGEMENT MARKET BY PRODUCT, 2016 – 2022, USD MILLION
TABLE 57 NIGERIA CLOT MANAGEMENT MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 58 NIGERIA CLOT MANAGEMENT MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 59 REST OF LAMEA CLOT MANAGEMENT MARKET, 2012 – 2015, USD MILLION
TABLE 60 REST OF LAMEA CLOT MANAGEMENT MARKET, 2016 – 2022, USD MILLION
TABLE 61 REST OF LAMEA CLOT MANAGEMENT MARKET BY PRODUCT, 2012 – 2015, USD MILLION
TABLE 62 REST OF LAMEA CLOT MANAGEMENT MARKET BY PRODUCT, 2016 – 2022, USD MILLION
TABLE 63 REST OF LAMEA CLOT MANAGEMENT MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 64 REST OF LAMEA CLOT MANAGEMENT MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 65 KEY INFORMATION –TELEFLEX INC.
TABLE 66 KEY INFORMATION –EDWARDS LIFESCIENCES CORPORATION
TABLE 67 KEY INFORMATION – MEDTRONIC PLC
TABLE 68 KEY INFORMATION – BOSTON SCIENTFIC CORPORATION
TABLE 69 KEY INFORMATION –LEMAITRE VASCULAR INC.
TABLE 70 KEY INFORMATION –STRAUB MEDICAL AG
TABLE 71 KEY INFORMATION –COOK MEDICAL INC.
TABLE 72 KEY INFORMATION – JOHNSON & JOHNSON
